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Background
Pulmonary arterial hypertension (PAH) is characterized
by progressive increase in pulmonary vascular resistance
(PVR), leading to right ventricular (RV) failure [1]. PVR
is calculated using right heart catheterization (RHC),
from the trans-pulmonary pressure gradient (ΔP) and
pulmonary flow (QPA). Doppler echocardiography can
estimate PVR from the ratio of peak tricuspid regurgita-
tion velocity (TRV) to main pulmonary artery velocity
time-integral (MPA flow) [2]. MRI is increasingly used
to assess right ventricular (RV) function in PAH. Deter-
mining PVR from MRI could enable a more complete
characterization of RV and PA interactions in PAH. The
purpose of this study was to non-invasively estimate
PVR from TRV/QPA using a 4D flow-sensitive MRI
sequence in humans [3].
Methods
Six PAH patients referred for right heart catheterization
(RHC) and six healthy volunteers were scanned accord-
ing to an IRB-approved protocol. In patients, RHC was
performed clinically within 1 week of the MRI in
patients with PAH. PVRRHC was calculated as follows:
PVR=ΔP/QPA. 4D flow MRI (Phase Contrast with
Vastly undersampled Isotropic Projection Reconstruc-
tion - PC VIPR) was performed on 3T clinical scanners
(GE Healthcare, Waukesha, WI) after the administration
of gadolinium-based contrast agents. PC VIPR para-
meters: FOV=32 x 32 x 22 cm, isotropic 1.3 mm spatial
resolution, TR/TE = 6.3/2.1 ms, Venc=150 cm/s, scan
time: ~10 min using respiratory and retrospective ECG
gating. Post-processing was done using Ensight (CEI,
Apex, NC) and MatLab (The Mathworks, Natick, MA)
to measure peak TRV and QPA. Statistical analysis
included regression analysis to evaluate the correlation
between TRV/QPA and PVRRHC. A regression equa-
tion was derived to calculate PVRMRI. Differences
between PVRMRI and PVRRHC were assessed using
Bland-Altman analysis. TRV/QPA ratios in healthy con-
trols were compared to those in PAH patients using
Student t-test.
Results
Average (± standard deviation) PVRRHC was 7.15 ±
3.56 UW. The Pearson correlation coefficient between
TRV/QPA and PVRRHC was 0.94. The equation derived
from linear regression was PVRMRI = 0.69*PVRRHC -
2.84 UW. Using this equation, the average (± standard
deviation) PVRMRI was 7.15 ± 3.35 (p=0.99). The mean
difference between PVRMRI and PVRRHC was 0 with
positive and negative levels of agreement of 2.4 and -2.4,
respectively. Differences in TRV/QPA in healthy con-
trols and PAH patients were statistically significant
(p=0.0003).
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Figure 1 Scatter plot demonstrating relationship between TRV/QPA
from 4D Flow (y axis) and PVR from RHC (x axis).
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Conclusions
PVR can be accurately estimated noninvasively using 4D
flow MRI. The results from this study indicate that 4D
flow-sensitive MRI with PC VIPR can also be used to
estimate PVR, complementing the analysis of alterations
in flow patterns in the heart and pulmonary arteries in
patients with cardiopulmonary disease. Data from a dif-
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Figure 2 TRV/QPA comparison between PAH patients and healthy
controls. Differences are statistically significant (p=0.0003)
Roldán-Alzate et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):P128
http://www.jcmr-online.com/content/15/S1/P128
Page 2 of 2
